According to Mirum Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -4,33ย โฌ. In 2022 the company made an earnings per share (EPS) of -3,66ย โฌ a decrease over its 2021 EPS that were of -2,55ย โฌ.